An Extended Treatment Study of MT-3995 in Patients With Diabetic Nephropathy
A phase 2 trial registered on ClinicalTrials.gov. The registry status is completed. It enrolled 241 participants.
Also called NCT02676401
- Study
- In this atlas
Overview
- Design
- Interventional study; randomized; no masking; primary purpose treatment
- Phase
- Phase 2
- Enrolled
- 241 participants
- Sponsor
- Registry
-
NCT02676401
-
- Start date
- (registry gives no type)
- Primary completion
- (actual)
- Completion
- Not reported
- Countries
- Japan
- Registry status
- Completed
Technical summary
Registry record NCT02676401. Randomized; no masking; primary purpose treatment. Start 2016-02 (registry gives no type); primary completion 2017-08 (actual). Results not posted.
The registry's words
Labels as the registry gives them, not rewritten.
- Brief title
- An Extended Treatment Study of MT-3995 in Patients With Diabetic Nephropathy
- Condition
- Diabetic Nephropathy
- Intervention (Drug)
- MT-3995 Low
- Intervention (Drug)
- MT-3995 Middle
- Intervention (Drug)
- MT-3995 High
- Lead sponsor
- Tanabe Pharma Corporation
Record details
- Record id
cardio:ct-nct02676401- Content hash
2b56ce1169f905d2cdbc511c120730860b9326e560d072c71049004a25942a8e